GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Universal Health International Group Holding 2211.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.46

-3.16%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Universal Health International Group Holding

Its shares trade on HKEX under the ticker 2211.HK. It has been listed since 12 December 2013. In the fiscal year to 30 June 2025, it reported revenue of CN¥711.5m and a net loss of CN¥26.0m. At that date it held total assets of CN¥447.6m and shareholders' equity of CN¥317.6m.

Universal Health International Group Holding Ltd. is an investment company, which engages in the market, distribution, and sale of drugs and pharmaceutical products. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2013-12-12. The firm operates its business through four segments: Distributions, Retails I, Retails II and Others. The Others segment is engaged in investment business. Through its subsidiaries, the Company is also engaged in e-commerce and trading of health-care products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
12 Dec 2013
Employees
5,628

Leadership

Pay as last reported

  • Mr. Chuanfu ChuExecutive Chairman of the Board, Chief Executive Officer, Chief Operating Officer, since 2012CN¥470,000
  • Mr. Dongkun JinExecutive Vice Chairman of the Board, since 2012CN¥512,000
  • Mr. Zehua ZhaoGeneral Manager - Finance, Executive Director, since 2011CN¥470,000
  • Ms. Kit Ying HuiCompany Secretary
  • Mr. Sheung Hing ChengIndependent Non-Executive DirectorCN¥152,000
  • Ms. Su Hui ChiangIndependent Non-Executive DirectorCN¥152,000
  • Mr. Haiyan ZouIndependent Non-Executive DirectorCN¥152,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Operates through four business segments including Distributions and Retails I
  • Employs 5,628 full-time employees in Shenyang, Liaoning
  • Engages in e-commerce and trading of health-care products through subsidiaries

Weaknesses

  • Listed on 12 December 2013 with no recent expansion details
  • Headquartered in Shenyang, Liaoning, a city not known for pharmaceutical innovation
  • No mention of international market presence beyond China

Opportunities

  • Growth in China's Health Care sector with increasing demand for pharmaceuticals
  • Expansion into e-commerce platforms for health-care product distribution
  • Potential for new partnerships in the Chinese pharmaceutical market

Threats

  • Competition from established pharmaceutical companies in China
  • Regulatory changes in China's Health Care industry could impact operations
  • Economic downturns affecting consumer spending on health-care products

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.